An Evaluation of Cystatin C Levels in the Serum and Urine as Early Diagnostic for Iraqi Patients with Type 2 Diabetes
Keywords:
Diabetic Nephropathy, Urine Cystatin C, Serum Cystatin C.Abstract
The current study the effect of urine and serum cystatin in diabetic nephropathy patients in Najaf. This investigation was carried out at the Al-Sadr Teaching Hospital in Najaf's Diabetes and Endocrine Center for a period from May 2022 to October 2022. the study included 42 males with diabetic type 2 ranging in age from 30 to 62. they were divided into 3 groups intended UACR and were divided, into two groups depending on Egfr and evaluated serum and urine cystatin C, HbA1C, creatinine, urea, UACR, Egfr, lipid profile, CRP. The result of the current study according to albuminuria showed no significance in age, duration of diabetes, BMI, cholesterol, HDL, VLDL, while this study registered significance (p<0.05) in HbA1C, UACR, Serum CR, eGFR, urea, TG, CRP, serum cystatin and urine cystatin. So, when comparing eGFR stages were found higher significance(p<0.001) in UACR, eGFR, and (p<0.05) serum CR, Urea, TG, CRP, serum cystatin, and urine cystatin. ROC for cystatin C was 0.703 and ROC for urine cystatin was 0.802. The negative relationship between eGFR and urine cystatin C levels, serum cystatin C levels and (serum creatinine) {R = - 0.438, p = 0.003}, {R = - 0.416 , p = 0.010 }, { R = - 0.557, p = 0.009}. in conclusion Urine and serum cystatin maybe use a marker besides creatinine to diagnose early kidney dysfunction.
Downloads
References
Kittell F. Diabetes Management. Thomas LK,
Othersen JB Nutr Ther Chronic Kidney
Dis CRC Press pp. 2012;198.
Bengtsson E, To F, Håkansson K, Grubb A,
Brånén L, Nilsson J, et al. Lack of the
cysteine protease inhibitor cystatin C
promotes atherosclerosis in apolipoprotein
E–deficient mice. Arterioscler Thromb
Vasc Biol.2005;25(10):2151–6.
Hojs R, Bevc S, Ekart R, Gorenjak M,
Puklavec L. Serum cystatin C as an
endogenous marker of renal function in
patients with mild to moderate impairment
of kidney function. Nephrol Dial
Transplant.2006;21(7):1855–62.
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn
JD, Confavreux C, et al. Endocrine
regulation of energy metabolism by the
skeleton. Cell. 2007;130(3):456–69.
Gashenko EA, Lebedeva VA, Brak I V,
Tsykalenko EA, Vinokurova G V,
Korolenko TA. Evaluation of serum
procathepsin B, cystatin B and cystatin C
as possible biomarkers of ovarian cancer.
Int J Circumpolar Health.
;72(1):21215.Benson K, Cramer S, Galla H-J. Impedancebased cell monitoring: barrier properties
and beyond. Fluids Barriers CNS.
;10(1):1–11.
Saitoh E, Sabatini LM, Eddy RL, Shows TB,
Azen EA, Isemura S, et al. The human
cystatin C gene (CST3) is a member of the
cystatin gene family which is localized on
chromosome 20. Biochem Biophys Res
Commun. 1989;162(3):1324–31.
Shemesh O, Golbetz H, Kriss JP, Myers BD.
Limitations of creatinine as a filtration
marker in glomerulopathic patients.
Kidney Int. 1985;28(5):830–8.
Aščić-Buturović B, Čavaljuga S. Cystatin C as
a marker for detection of early renal failure
in diabetes type 2 patients. Bosn J Basic
Med Sci. 2005;5(4):68.
Rule AD, Larson TS, Bergstralh EJ, Slezak
JM, Jacobsen SJ, Cosio FG. Using serum
creatinine to estimate glomerular filtration
rate: accuracy in good health and in
chronic kidney disease. Ann Intern Med.
;141(12):929–37.
Rao X, Wan M, Qiu C, Jiang C. Role of cystatin
C in renal damage and the optimum cut‑off
point of renal damage among patients with
type 2 diabetes mellitus. Exp Ther Med.
;8(3):887–92.
Garg V, Kumar M, Mahapatra HS, Chitkara
A, Gadpayle AK, Sekhar V. Novel urinary
biomarkers in pre-diabetic nephropathy.
Clin Exp Nephrol. 2015;19(5):895–900.
Ibrahim MA, Ahmed YS, El-Shinnawy HA,
Maseeh I, Makkeyah YM, Bichari WA.
Value of urinary cystatin C in early
detection of diabetic nephropathy in type
diabetes mellitus. Int J Adv Res Biol Sci.
;2(3):211–23.
Levey AS, Bosch JP, Lewis JB, Greene T,
Rogers N, Roth D, et al. A more accurate
method to estimate glomerular filtration
rate from serum creatinine: a new
prediction equation. Ann Intern Med.
;130(6):461–70.
Myers GL, Miller WG, Coresh J, Fleming J,
Greenberg N, Greene T, et al. National
Kidney Disease Education Program
Laboratory Working Group:
Recommendations for improving serum
creatinine measurement: A report from the
laboratory working group of the national
kidney disease education program. Clin
Chem. 2006;52(1):5–18.
Stevens LA, Coresh J, Schmid CH, Feldman
HI, Froissart M, Kusek J, et al. Estimating
GFR using serum cystatin C alone and in
combination with serum creatinine: a
pooled analysis of 3,418 individuals with
CKD. Am J kidney Dis. 2008;51(3):395–
Jeon YK, Kim MR, Huh JE, Mok JY, Song
SH, Kim SS, et al. Cystatin C as an early
biomarker of nephropathy in patients with
type 2 diabetes. J Korean Med Sci.
;26(2):258–63.
Hirai M, Suzuki S, Hinokio Y, Hirai A, Chiba
M, Akai H, et al. Variations in vitamin Dbinding protein (group-specific
component protein) are associated with
fasting plasma insulin levels in Japanese
with normal glucose tolerance. J Clin
Endocrinol Metab. 2000;85(5):1951–3.
Kim SS, Song SH, Kim IJ, Jeon YK, Kim
BH, Kwak IS, et al. Urinary cystatin C
and tubular proteinuria predict progression
of diabetic nephropathy. Diabetes Care.
;36(3):656–61.
Najjar ZSR, Jwad SM, Alkhafaji RS.
Assessment of 1.25 (OH) 2D3 Levels and
Nephropathy Stages in Adult Male
Patients with Type-2 Diabetes Mellitus.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
